IL109664A0 - Peptides of human influenza virus for use in human t cell response inducing compositions - Google Patents

Peptides of human influenza virus for use in human t cell response inducing compositions

Info

Publication number
IL109664A0
IL109664A0 IL10966494A IL10966494A IL109664A0 IL 109664 A0 IL109664 A0 IL 109664A0 IL 10966494 A IL10966494 A IL 10966494A IL 10966494 A IL10966494 A IL 10966494A IL 109664 A0 IL109664 A0 IL 109664A0
Authority
IL
Israel
Prior art keywords
human
peptides
influenza virus
cell response
response inducing
Prior art date
Application number
IL10966494A
Original Assignee
Rijksuniversiteit
Seed Capital Investments
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit, Seed Capital Investments filed Critical Rijksuniversiteit
Publication of IL109664A0 publication Critical patent/IL109664A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
IL10966494A 1993-05-18 1994-05-17 Peptides of human influenza virus for use in human t cell response inducing compositions IL109664A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201429 1993-05-18

Publications (1)

Publication Number Publication Date
IL109664A0 true IL109664A0 (en) 1994-08-26

Family

ID=8213836

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10966494A IL109664A0 (en) 1993-05-18 1994-05-17 Peptides of human influenza virus for use in human t cell response inducing compositions

Country Status (4)

Country Link
AU (1) AU6858594A (en)
IL (1) IL109664A0 (en)
WO (1) WO1994026903A2 (en)
ZA (1) ZA943438B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020127A1 (en) * 1993-03-05 1994-09-15 Cytel Corporation Hla-a2.1 binding peptides and their uses
CA2168950A1 (en) * 1993-08-06 1995-02-16 Esteban Celis Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of ctl
US6458354B1 (en) 1996-03-28 2002-10-01 The Johns Hopkins University Molecular complexes which modify immune responses
WO1997035991A1 (en) 1996-03-28 1997-10-02 The Johns Hopkins University Soluble divalent and multivalent heterodimeric analogs of proteins
US6268411B1 (en) * 1997-09-11 2001-07-31 The Johns Hopkins University Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
GB0716992D0 (en) 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
PT1968632E (en) 2005-12-06 2012-07-16 Yeda Res & Dev Improved influenza vaccine
GB0613977D0 (en) 2006-02-07 2006-08-23 Peptcell Ltd Peptide sequences and compositions
EP1843158A1 (en) * 2006-04-05 2007-10-10 Micronas Holding GmbH Pathogen detection system
AU2007314550A1 (en) 2006-05-18 2008-05-08 Pharmexa Inc. Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
WO2009109428A2 (en) * 2008-02-01 2009-09-11 Alpha-O Peptides Ag Self-assembling peptide nanoparticles useful as vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
WO1994026903A3 (en) 1995-06-01
ZA943438B (en) 1995-01-20
WO1994026903A2 (en) 1994-11-24
AU6858594A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
IL116512A0 (en) Cyclic peptides their preparation and pharmaceutical compositions containing them
IL116458A0 (en) Aerosol formulations of peptides and proteins
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
IL114578A0 (en) Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
AU8762991A (en) Human papilloma viral protein expression for use in vaccine compositions
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
NZ220365A (en) Antiviral peptides and pharmaceutical compositions
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
IL109664A0 (en) Peptides of human influenza virus for use in human t cell response inducing compositions
ATE186541T1 (en) QUILLAJASAPONIN SUPPLEMENT AND VACCINE FORMULATION CONTAINING SAME
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL113484A0 (en) Viral proteins pharmaceutical compositions containing them their preparation and use
GB9516293D0 (en) Novel peptides and their use as vaccines
ZA96240B (en) Novel peptides their preparation and use
ZA96239B (en) Novel peptides their preparation and use
GB9313556D0 (en) Synthetic peptides of human papillomavirus
IL113415A0 (en) Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
ZA933135B (en) Peptides of human papilloma virus for use in human T cell response inducing compositions
IL106214A0 (en) Thf-ypsilon2 analogs and pharmaceutical compositions comprising them
GB9304745D0 (en) Use of pharmaceutical formulations
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
NZ245239A (en) Hemoregulatory peptides and pharmaceutical compositions
IL127080A0 (en) The use of peptides derived from zona pelucida proteins for contraception and pharmaceutical compositions containing the same
GB9412915D0 (en) Synthetic peptides of human papillomavirus